Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical experience on the limited role of ultrasound for breast cancer screening in BRCA1 and BRCA2 mutations carriers aged 30-39 years.

Clinical imaging - 1 Dec 2024

Bufman Hila, Sorin Vera, Faermann Renata, Bernstein-Molho Rinat, Friedman Eitan, Barash Yiftach, Lahat Nora Balint, Sklair-Levy Miri

Abstract excerpt

PURPOSE: In BRCA germline pathogenic sequence variants (PSV) carriers aged 30-39 years imaging is recommended at six-month intervals. The European society for medical oncology recommendation of the use of 6-monthly MRI six-monthly MRI screening is being considered at our institution, particularly for younger carriers under the age of 35, although it is not mandatory. If 6-monthly MRI is unavailable, annual MRI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Early Detection of Cancer

Share to Heterozygote

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Mutation

Source

Identifiers

PMID: 39393341
DOI: 10.1016/j.clinimag.2024.110310

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical experience on the limited role of ultrasound for breast cancer screening in BRCA1 and BRCA2 mutations carriers aged 30-39 years.PMID 39393341Read ↗

High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

Impact of the 2018 ACR Supplemental Screening Recommendations on MRI Eligibility in Breast Cancer Survivors.Semantic proximity Read ↗

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.Semantic proximity Read ↗

Breast cancer screening of pregnant and breastfeeding women with BRCA mutations.Semantic proximity Read ↗

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.Semantic proximity Read ↗

Imaging Characteristics of Breast Cancers Detected During MRI-Based Surveillance in Hereditary Breast and Ovarian Cancer SyndromeSemantic proximity Read ↗

MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.Semantic proximity Read ↗

The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations.Semantic proximity Read ↗

Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016.Semantic proximity Read ↗

Screening for hereditary breast cancer.Semantic proximity Read ↗

Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.